6 ms·

This does not appear to be new - there's a story from last year here: http://med.stanford.edu/ism/2013/may/cd47.html http://med.stanford.edu/ism/2013/may/cd47.h

• lampington 13y ago
  The original story above is from March 27, 2013. Perhaps the OP didn't see the year?
• weirdcat 13y ago
  From http://stemcell.stanford.edu/CD47/ http://stemcell.stanford.edu/CD47/: TL;DR: Clinical trials expected in the first half of 2014 (1/14/14) Update on the anti-CD47 cancer therapy clinical trials Researchers and staff at Stanford are continuing to work hard preparing the groundwork for the clinical trials of our anti-CD47 antibody as a cancer therapy. We are anticipating the start of clinical trials sometime in the first half of this year, though unforeseen delays may yet slow that progress. As we get closer to the start of the clinical trials, we will be posting information about eligibility for the trials and how to apply. There has been a huge amount of interest in these trials from patients and their families and friends. However, we feel compelled to emphasize that, as is typical of FDA phase I clinical trials, the first tests of this therapy will be very small safety trials involving only a very few patients. Unfortunately, this means only a tiny fraction of those interested will be admitted to the first phase I clinical trials. Accordingly, we are urging patients to continue exploring existing treatments and other clinical trials.